Unknown

Dataset Information

Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols.


ABSTRACT: Central nervous system (CNS) disorders, such as psychiatric disorders, neurodegeneration, chronic pain, stroke, brain tumor, spinal cord injury, and many other CNS diseases, would hugely benefit from specific and potent peptide pharmaceuticals and their low inherent toxicity. The delivery of peptides to the brain is challenging due to their low metabolic stability, which decreases their duration of action, poor penetration of the blood-brain barrier (BBB), and their incompatibility with oral administration, typically resulting in the need for parenteral administration. These challenges limit peptides' clinical application and explain the interest in alternative routes of peptide administration, particularly nose-to-brain (N-to-B) delivery, which allows protein and peptide drugs to reach th

SUBMITTER: Alabsi W 

PROVIDER: S-EPMC9502087 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature